4.5 Article

Genome-Wide Association Study of the Child Behavior Checklist Dysregulation Profile

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jaac.2011.05.001

Keywords

ADHD; emotional dysregulation; CBCL; GWAS

Funding

  1. Pfizer Inc.
  2. National Institute of Health (NIH) [R13MH059126, R01MH62873, U0IMH085518, R01MH081803]
  3. National Institute of Neurological Disorders and Stroke (NINDS) [NS054124]
  4. National Institute of Mental Health (NIMH) [MH01966, MH01805, MH63706, K08MH001503, R01MH066237]
  5. National Institute on Drug Abuse (NIDA) [K24 DA016264]
  6. Ortho-Mcneil Janssen Scientific Affairs
  7. Pfizer
  8. Shire Pharmaceuticals
  9. Elminda
  10. Janssen
  11. McNeil
  12. Shire
  13. Abbott
  14. Alza
  15. AstraZeneca
  16. Bristol Myers Squibb
  17. Celltech
  18. Cephalon
  19. Eli Lilly and Co.
  20. Esai
  21. Forest
  22. Glaxo
  23. Gliatech
  24. Merck
  25. National Alliance for Research on Schizophrenia and Depression (NARSAD)
  26. National Institute on Drug Abuse (NIDA)
  27. New River
  28. National Institute of Child Health and Human Development (NICHD)
  29. National Institute of Mental Health (NIMH)
  30. Novartis
  31. Noven
  32. Neurosearch
  33. Organon
  34. Otsuka
  35. Pharmacia
  36. Prechter Foundation
  37. Stanley Foundation
  38. UCB Pharma, Inc.
  39. Wyeth
  40. Bristol-Myers Squibb
  41. Aspect
  42. Seaside Pharmaceuticals
  43. National Institutes of Health (NIH) - NIDA
  44. Guilford Press
  45. Bantam Books
  46. NIH

Ask authors/readers for more resources

Objective: : A potentially useful tool for understanding the distribution and determinants of emotional dysregulation in children is a Child Behavior Checklist profile, comprising the Attention Problems, Anxious/Depressed, and Aggressive Behavior clinical subscales (CBCL-DP). The CBCL-DP indexes a heritable trait that increases susceptibility for later psychopathology, including severe mood problems and aggressive behavior. We have conducted a genome-wide association study of the CBCL-DP in children with attention-deficit/hyperactivity disorder (ADHD). Method: Families were ascertained at Massachusetts General Hospital and University of California, Los Angeles. Genotyping was conducted with the Illumina Human1M or Human1M-Duo Bead Chip platforms. Genome-wide association analyses were conducted with the MQFAM multivariate extension of PLINK. Results: CBCL data were available for 341 ADHD offspring from 339 ADHD affected trio families from the UCLA (N = 128) and the MGH (N = 213) sites. We found no genome-wide statistically significant associations but identified several plausible candidate genes among findings at p < 5E-05: TMEM132D, LRRC7, SEMA3A, ALK, and STIP1. Conclusions: We found suggestive evidence for developmentally expressed genes operant in hippocampal dependent memory and learning with the CBCL-DP. J. Am. Acad. Child Adolesc. Psychiatry, 2011;50(8): 807-817.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available